Login/Sign Up
Tasigna 200 mg Capsule 4's belongs to the class of anticancer drugs called tyrosine kinase inhibitors used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Ph+ CML is a type of blood cancer that causes white blood cells to behave differently.
Tasigna 200 mg Capsule 4's contains Nilotinib which works by blocking the action of an abnormal protein (Bcr-Abl tyrosine kinase) produced by an abnormal Philadelphia chromosome that signals abnormal white blood cells (cancerous cells) to multiply. Thereby, it stops the multiplication and inhibits the growth of cancerous cells and then causes the death of these cells.
Take Tasigna 200 mg Capsule 4's as prescribed. You are recommended to take Tasigna 200 mg Capsule 4's for as long as your doctor has advised it for you based on your medical condition. Sometimes, Tasigna 200 mg Capsule 4's may cause common side effects such as vomiting, nausea, diarrhoea, headache, constipation, tiredness, and muscle and joint pain. Most of these side effects of Tasigna 200 mg Capsule 4's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Nilotinib or any other medicines, please tell your doctor. Avoid taking Tasigna 200 mg Capsule 4's if you are pregnant or breastfeeding. You are recommended to use effective contraceptive methods while taking Tasigna 200 mg Capsule 4's and for two weeks after completing the course of Tasigna 200 mg Capsule 4's. Tasigna 200 mg Capsule 4's is not recommended for children below one year of age. Drive only if you are alert as Tasigna 200 mg Capsule 4's may cause dizziness or visual disorders as side effects in some people. If you have yellow skin and eyes, dark-coloured urine, or stomach pain while taking Tasigna 200 mg Capsule 4's, contact your doctor immediately, as these might be symptoms of liver problems.
Tasigna 200 mg Capsule 4's contains Nilotinib, an anticancer drug used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). In chronic myeloid leukemia (CML) patients, a change in genetic material (DNA) triggers a signal that tells the body to produce more abnormal white blood cells (cancerous cells). Nilotinib works by blocking this signal and thus stops the production of cancerous cells. Tasigna 200 mg Capsule 4's is used in adults and children with newly diagnosed Ph+ CML in the chronic phase and in adults with Ph+ CML in the accelerated and chronic phase who did not tolerate or no longer benefit from other treatments, including Imatinib.
If you are allergic to Nilotinib or any other medicines, please tell your doctor. Avoid taking Tasigna 200 mg Capsule 4's if you are pregnant or breastfeeding. You are recommended to use effective contraceptive methods while taking Tasigna 200 mg Capsule 4's and for two weeks after completing the course of Tasigna 200 mg Capsule 4's. Tasigna 200 mg Capsule 4's is not recommended for children below one year of age. Tasigna 200 mg Capsule 4's may affect the growth and development of children with chronic phase Ph+ CML. Some children and adolescents may have slower than normal growth while taking Tasigna 200 mg Capsule 4's. Therefore, your doctor will monitor the growth of your child at regular visits. Drive only if you are alert as Tasigna 200 mg Capsule 4's may cause dizziness or visual disorders as side effects in some people. Tasigna 200 mg Capsule 4's may increase the risk of liver problems, especially in people with a history of liver problems. Therefore, if you have yellow skin and eyes, dark-coloured urine, or stomach pain while taking Tasigna 200 mg Capsule 4's, contact your doctor immediately, as these might be symptoms of liver problems. Inform your doctor if you have a severe problem with lactose (milk sugar) or other sugars as Tasigna 200 mg Capsule 4's may contain lactose. Most people who have mild or moderate lactose intolerance can take Tasigna 200 mg Capsule 4's. Avoid taking Tasigna 200 mg Capsule 4's if you have low levels of magnesium or potassium in the blood or long QTc syndrome. If you have had a surgical procedure involving the removal of the entire stomach (total gastrectomy), inform your doctor before taking Tasigna 200 mg Capsule 4's.
Drug-Drug Interaction: Tasigna 200 mg Capsule 4's may interact with anti-arrhythmic drugs (disopyramide, quinidine, amiodarone, sotalol, procainamide), antibiotics (clarithromycin, moxifloxacin), antimalarial drugs (chloroquine), antipsychotics (haloperidol, pimozide), opioid analgesics (methadone, fentanyl, alfentanil), anticonvulsants (phenytoin, carbamazepine, phenobarbital), blood thinner (warfarin), anti-HIV drug (rifampicin), antifungals (itraconazole, ketoconazole, voriconazole) and immunosuppressants (cyclosporine, tacrolimus, sirolimus). Inform your doctor if you are using any medicines before taking Tasigna 200 mg Capsule 4's.
Drug-Food Interaction: Avoid grapefruit juice, grapefruit and any supplement containing grapefruit extract while taking Tasigna 200 mg Capsule 4's as it may increase the amount of Nilotinib in the body and cause serious side effects. Also, Tasigna 200 mg Capsule 4's may interact with St. John’s wort (a herbal product used to treat depression).
Drug-Disease Interaction: Avoid taking Tasigna 200 mg Capsule 4's if you have low levels of magnesium or potassium in the blood or long QTc syndrome. If you have had pancreatitis, stroke or other problems due to decreased blood flow to the brain, have QTc prolongation or a family history of it, bleeding problems, irregular heartbeat, have low problems with decreased blood flow to your legs, have low levels of magnesium or potassium in blood, heart or liver problems, inform your doctor before taking Tasigna 200 mg Capsule 4's.
Regular tests are recommended during treatment with Tasigna 200 mg Capsule 4's:
Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML): It is a common form of chronic myeloid leukemia (CML) that occurs when specific chromosomes swap positions, causing an abnormality in the chromosomes, creating the Philadelphia chromosome. The abnormal chromosomes produce an abnormal protein called Bcr-Abl tyrosine kinase, which then triggers a signal to produce abnormal white blood cells in the bone marrow. CML is a type of blood cancer which makes the body produce too many abnormal white blood cells. Many people with Ph+ CML will not experience symptoms before their diagnosis. However, if symptoms do occur, they include weight loss, weakness, night sweats, extreme tiredness, feeling full after only small meals, bone pain, and easy bleeding.
About Tasigna 200 mg Capsule 4's
Tasigna 200 mg Capsule 4's belongs to the class of anticancer drugs called tyrosine kinase inhibitors used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Ph+ CML is a type of blood cancer that causes white blood cells to behave differently.
Tasigna 200 mg Capsule 4's contains Nilotinib which works by blocking the action of an abnormal protein (Bcr-Abl tyrosine kinase) produced by an abnormal Philadelphia chromosome that signals abnormal white blood cells (cancerous cells) to multiply. Thereby, it stops the multiplication and inhibits the growth of cancerous cells and then causes the death of these cells.
Take Tasigna 200 mg Capsule 4's as prescribed. You are recommended to take Tasigna 200 mg Capsule 4's for as long as your doctor has advised it for you based on your medical condition. Sometimes, Tasigna 200 mg Capsule 4's may cause common side effects such as vomiting, nausea, diarrhoea, headache, constipation, tiredness, and muscle and joint pain. Most of these side effects of Tasigna 200 mg Capsule 4's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Nilotinib or any other medicines, please tell your doctor. Avoid taking Tasigna 200 mg Capsule 4's if you are pregnant or breastfeeding. You are recommended to use effective contraceptive methods while taking Tasigna 200 mg Capsule 4's and for two weeks after completing the course of Tasigna 200 mg Capsule 4's. Tasigna 200 mg Capsule 4's is not recommended for children below one year of age. Drive only if you are alert as Tasigna 200 mg Capsule 4's may cause dizziness or visual disorders as side effects in some people. If you have yellow skin and eyes, dark-coloured urine, or stomach pain while taking Tasigna 200 mg Capsule 4's, contact your doctor immediately, as these might be symptoms of liver problems.
₹6970*
MRP ₹8500
18% off
₹7225*
MRP ₹8500
15% CB
₹1275 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Product Substitutes
Uses of Tasigna 200 mg Capsule 4's
Medicinal Benefits
Tasigna 200 mg Capsule 4's contains Nilotinib, an anticancer drug used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). In chronic myeloid leukemia (CML) patients, a change in genetic material (DNA) triggers a signal that tells the body to produce more abnormal white blood cells (cancerous cells). Nilotinib works by blocking this signal and thus stops the production of cancerous cells. Tasigna 200 mg Capsule 4's is used in adults and children with newly diagnosed Ph+ CML in the chronic phase and in adults with Ph+ CML in the accelerated and chronic phase who did not tolerate or no longer benefit from other treatments, including Imatinib.
Side Effects of Tasigna 200 mg Capsule 4's
Directions for Use
Storage
Drug Warnings
If you are allergic to Nilotinib or any other medicines, please tell your doctor. Avoid taking Tasigna 200 mg Capsule 4's if you are pregnant or breastfeeding. You are recommended to use effective contraceptive methods while taking Tasigna 200 mg Capsule 4's and for two weeks after completing the course of Tasigna 200 mg Capsule 4's. Tasigna 200 mg Capsule 4's is not recommended for children below one year of age. Tasigna 200 mg Capsule 4's may affect the growth and development of children with chronic phase Ph+ CML. Some children and adolescents may have slower than normal growth while taking Tasigna 200 mg Capsule 4's. Therefore, your doctor will monitor the growth of your child at regular visits. Drive only if you are alert as Tasigna 200 mg Capsule 4's may cause dizziness or visual disorders as side effects in some people. Tasigna 200 mg Capsule 4's may increase the risk of liver problems, especially in people with a history of liver problems. Therefore, if you have yellow skin and eyes, dark-coloured urine, or stomach pain while taking Tasigna 200 mg Capsule 4's, contact your doctor immediately, as these might be symptoms of liver problems. Inform your doctor if you have a severe problem with lactose (milk sugar) or other sugars as Tasigna 200 mg Capsule 4's may contain lactose. Most people who have mild or moderate lactose intolerance can take Tasigna 200 mg Capsule 4's. Avoid taking Tasigna 200 mg Capsule 4's if you have low levels of magnesium or potassium in the blood or long QTc syndrome. If you have had a surgical procedure involving the removal of the entire stomach (total gastrectomy), inform your doctor before taking Tasigna 200 mg Capsule 4's.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Regular tests are recommended during treatment with Tasigna 200 mg Capsule 4's:
Disease/Condition Glossary
Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML): It is a common form of chronic myeloid leukemia (CML) that occurs when specific chromosomes swap positions, causing an abnormality in the chromosomes, creating the Philadelphia chromosome. The abnormal chromosomes produce an abnormal protein called Bcr-Abl tyrosine kinase, which then triggers a signal to produce abnormal white blood cells in the bone marrow. CML is a type of blood cancer which makes the body produce too many abnormal white blood cells. Many people with Ph+ CML will not experience symptoms before their diagnosis. However, if symptoms do occur, they include weight loss, weakness, night sweats, extreme tiredness, feeling full after only small meals, bone pain, and easy bleeding.